Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin

Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin

Bibliographic Details
Main Authors: Kageaki Watanabe, MD, Rui Kitadai, MD, Shingo Kitagawa, MD, Takashi Toya, MD, Yukio Hosomi, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:JTO Clinical and Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320300515
id doaj-7c17f28a323146c6b468074ac6c164c6
record_format Article
spelling doaj-7c17f28a323146c6b468074ac6c164c62021-03-19T07:29:20ZengElsevierJTO Clinical and Research Reports2666-36432020-09-0113100046Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With CyclosporinKageaki Watanabe, MD0Rui Kitadai, MD1Shingo Kitagawa, MD2Takashi Toya, MD3Yukio Hosomi, MD, PhD4Corresponding author. Address for correspondence: Kageaki Watanabe, MD, Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan.; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japanhttp://www.sciencedirect.com/science/article/pii/S2666364320300515
collection DOAJ
language English
format Article
sources DOAJ
author Kageaki Watanabe, MD
Rui Kitadai, MD
Shingo Kitagawa, MD
Takashi Toya, MD
Yukio Hosomi, MD, PhD
spellingShingle Kageaki Watanabe, MD
Rui Kitadai, MD
Shingo Kitagawa, MD
Takashi Toya, MD
Yukio Hosomi, MD, PhD
Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
JTO Clinical and Research Reports
author_facet Kageaki Watanabe, MD
Rui Kitadai, MD
Shingo Kitagawa, MD
Takashi Toya, MD
Yukio Hosomi, MD, PhD
author_sort Kageaki Watanabe, MD
title Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
title_short Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
title_full Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
title_fullStr Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
title_full_unstemmed Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
title_sort durvalumab-induced secondary pure red cell aplasia successfully treated with cyclosporin
publisher Elsevier
series JTO Clinical and Research Reports
issn 2666-3643
publishDate 2020-09-01
url http://www.sciencedirect.com/science/article/pii/S2666364320300515
work_keys_str_mv AT kageakiwatanabemd durvalumabinducedsecondarypureredcellaplasiasuccessfullytreatedwithcyclosporin
AT ruikitadaimd durvalumabinducedsecondarypureredcellaplasiasuccessfullytreatedwithcyclosporin
AT shingokitagawamd durvalumabinducedsecondarypureredcellaplasiasuccessfullytreatedwithcyclosporin
AT takashitoyamd durvalumabinducedsecondarypureredcellaplasiasuccessfullytreatedwithcyclosporin
AT yukiohosomimdphd durvalumabinducedsecondarypureredcellaplasiasuccessfullytreatedwithcyclosporin
_version_ 1724213321955016704

Similar Items